Biomarin Pharmaceutical: Q3 Earnings Insights

Biomarin Pharmaceutical BMRN reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:03 PM.

Here's what investors need to know about the announcement.

Earnings

Biomarin Pharmaceutical missed estimated earnings by 300.0%, reporting an EPS of $-0.04 versus an estimate of $-0.01.

Revenue was up $96.60 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.48 which was followed by a 5.18% increase in the share price the next day.

Here's a look at Biomarin Pharmaceutical's past performance:

To track all earnings releases for Biomarin Pharmaceutical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.